1[1]Sasayama S, Fujita M. Recent insights into coronary collateral circulation[J]. Circulation, 1992, 85(3): 1197～ 1204.
2[2]Ware JA, Simons M. Angiogenesis in ischemic heart disease[J]. Nat Med ,1997, 3(2): 158～ 164.
3[3]Coulier F, Pontaroti P, Roubin R, et al. An evolutionary perspective on the fibroblast growth facto (FGF) and FGF receptor families[J]. J Mol Eovl,1997,44: 43～ 56.
4[4]Ware JA, Simons M. Angiogenesis and cardiovascular disease[M]. New York: Oxford University Press, 1999.79 ～ 100.
5[5]Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3[J]. Circulation, 1996, 93: 1493～1495.
6[6]Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells[J]. Proc Natl Acad Sci USA, 1996, 93(6): 2576 ～ 2581.
7[7]Ware JA, Simons M. Angiogenesis and cardiovascular disease[M]. New York: Oxford University Press, 1999.101 ～ 127.
8[8]Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D(VEGF ～ D) is a ligand for the tyrosine kinase VEGF receptor 2(Flk1) and VEGF receptor[J].Proc Natl Acad Sci USA, 1998, 95(7): 548 ～ 553.
9[9]Thompson JA, Anderson KD, Dipietro JM, et al. Site-directe neovessel formation in vivo[J]. Science, 1998, 241:1349 ～1352.
10[10]MuhlhauserJ, Pili R, Merrill MJ, et al. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or non-secreted forms of acidic fibroblast growth factor[J]. Hum Gene Ther, 1995,6:1475～ 1465.
